ftInvstr
AMANTA · Healthcare ₹194.03 +2.0% Mkt Cap ₹751 Cr
← Search another stock

AMANTA

Healthcare Drug Manufacturers - Specialty & Generic
★ Watchlist ⧉ Add to bucket
₹194.03
+2.0% today · 30d +14.44%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for AMANTA. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-06-30
REVENUE
₹69 Cr
+5.35% YoY
NET PROFIT
₹3 Cr
-5.61% YoY
OPM
21.86%
-2.06pp YoY
EPS
₹0.85
PE 52.36
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-4.2% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
PEERPEROCE %
AMANTA52.36—
SUNPHARMA37.5721.44
DIVISLAB89.1821.56
ZYDUSLIFE24.6424.22
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
65
SCORE / 100
Overall
6-axis composite of the sections below.
Performance — —
Valuation STRETCHED 20
Growth STEADY 68
Profitability HIGH 75
Technicals STRONG 73
Risk LOW 90
Key Stats
TTM PE
52.36
P/B
3.09
52W HIGH
₹205.57
OFF HIGH
-5.61%
MKT CAP
₹751 Cr
◉ Active Signals
MACDBullish0.3685
RSI(14)Bullish61.75
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold AMANTA and at what entry.

Sign up freeSign in
AI-generated research based on publicly available data and ftInvstr's bias-safe quantitative models. Not investment advice. Past performance does not guarantee future results. Consult a SEBI-registered investment adviser before making any investment decision.